Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,585 | -11,028 | -8,306 | -6,026 | -3,213 |
| Depreciation Amortization | 57 | -107 | -66 | -61 | -243 |
| Accounts receivable | N/A | 173 | 173 | 173 | N/A |
| Other Working Capital | -878 | 152 | -445 | -363 | -503 |
| Other Operating Activity | 796 | 3,637 | 2,726 | 1,870 | 1,055 |
| Operating Cash Flow | $-2,610 | $-7,173 | $-5,918 | $-4,407 | $-2,904 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,228 | 4,866 | 4,212 | 5,045 | 2,703 |
| Investing Cash Flow | $1,228 | $4,866 | $4,212 | $5,045 | $2,703 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 60 | 2,280 | 1,930 | 4 | 0 |
| Other Financing Activity | 1,625 | 0 | 0 | -3 | -17 |
| Financing Cash Flow | $1,685 | $2,280 | $1,930 | $1 | $-17 |
| Beginning Cash Position | 1,244 | 1,271 | 1,271 | 1,271 | 1,271 |
| End Cash Position | 1,547 | 1,244 | 1,495 | 1,910 | 1,053 |
| Net Cash Flow | $303 | $-27 | $224 | $639 | $-218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,610 | -7,173 | -5,918 | -4,407 | -2,904 |
| Free Cash Flow | -2,610 | -7,173 | -5,918 | -4,407 | -2,904 |